Industry Insights

  1. Design And Function Of GMP Transition Spaces 6/12/2024

    In pharma/biotech GMP, there are several spaces that function as transition spaces, such as air locks. This deep dive discusses how procedure and arrangement can influence their effectiveness.

  2. The Evolution Of Gene Therapy: From Small Market Diseases To Broad Patient Populations 6/6/2023

    With innovation and vision, AAV-based genetic medicines have the potential to treat large market, complex diseases that affect hundreds of thousands of patients every year.

  3. Do We Really Understand Plasmid Quality's Effects On mRNA Production? 5/1/2025

    Two experts examine the current guidelines and specs for plasmid DNA and question whether our understanding is sufficient.

  4. Live-Cell Imaging Techniques 5/30/2023

    Explore how scientists are addressing research questions using live-cell imaging technology that has advanced in recent years to become more versatile and easily accessible.

  5. How To Double Up With A CDMO To Reduce Risk 12/12/2025

    Parallel operations with a CDMO can reduce risk and accelerate timelines by enabling simultaneous process development and manufacturing. Learn how this approach supports facility design.

  6. The US Drug Pricing System Needs to Be Fixed 6/16/2021

    Reforms to the U.S. drug pricing environment are required, but to improve patients’ health outcomes, reforms must be grounded in a comprehensive understanding of the current drug pricing system. Otherwise, policymakers will make things worse, not better.

  7. Overcoming Challenges In Ophthalmic Formulations Through Polymer Selection 8/27/2025

    The growing demand for ophthalmic drugs is driven by aging populations and increased screen time, which contributes to rising eye conditions. Explore innovative solutions in ophthalmic drug development.

  8. Key Trends And Developments In Injectable Drug Formulation And Delivery

    As the biopharmaceutical market continues to grow, explore the barriers facing manufacturers and how to best evaluate a drug substance's characteristics and determine the most appropriate delivery device.

  9. Sterile Injectable Therapies: Revolutionizing Lifecycle Management

    The right balance of technical understanding, logistics, regulatory guidelines, and knowledge about product stability and quality is crucial for capitalizing on the benefits of shifting delivery formats.

  10. Biosimilar Interchangeability: Regulatory & Practical Considerations 3/9/2022

    Biosimilar interchangeability refers to the possibility of exchanging the reference biological product with its biosimilar (or vice versa) or exchanging biosimilars of the same reference product. This article provides an up-to-date overview of regulatory and practical considerations regarding biosimilar interchangeability with an emphasis on the European perspective.